Hanford's Contract Manufacturing Overview

Founded by George C. Hanford in 1846, Hanford Pharmaceuticals is the only U.S.-based independent contract antibiotic finisher. Hanford is currently looking to increase business in our core competency of beta-lactam antibiotic manufacturing but is also diversifying itself outside of our traditional sterile antibiotic capabilities.

Hanford is committed to increasing diversification of our product and service offerings and we understand that our 30 years of experience in aseptic processing can be more broadly utilized. In order to capitalize on our experience, we have acquired an 84,000 square-foot facility and are currently developing the space for manufacturing, warehousing and laboratory support services of non beta-lactam products.

This facility will include both aseptic processing capability as well as space that can be used for non-sterile product manufacturing.

The facility will also provide the space necessary to increase Hanford’s ability to offer our broad range of contract pharmaceutical support services, including Validation Services, Analytical Methods Development, Regulatory and Document Support, Quality Control Testing and OSHA/FDA Required Safety and GMP Training, to name just a few.

The facility has sufficient space to accommodate multiple production installations with both clinical and commercial-scale output capabilities.

Hanford expects the facility to be ready for clinical support services by Q4, 2011.